Home/Filings/4/0001437749-24-030535
4//SEC Filing

Cittadine Andrew 4

Accession 0001437749-24-030535

CIK 0001645469other

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 7:44 PM ET

Size

9.6 KB

Accession

0001437749-24-030535

Insider Transaction Report

Form 4
Period: 2024-09-30
Cittadine Andrew
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-09-30+1,79140,404 total
  • Tax Payment

    Common Stock

    2024-09-30$6.74/sh535$3,60639,869 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-09-301,79112,864 total
    Common Stock (1,791 underlying)
Footnotes (5)
  • [F1]Effective on August 12, 2024, Monopar Therapeutics Inc effected a 5 to 1 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
  • [F2]Represents shares acquired on vesting and settlement of restricted stock units.
  • [F3]Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units.
  • [F4]On February 2, 2022, the reporting person was granted 13,000 restricted stock units, vesting 6/48ths (1,625 shares) on June 30, 2022, and 3/48ths (813 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
  • [F5]On February 1, 2023, the reporting person was granted 15,647 restricted stock units, vesting 6/48ths (1,956 shares) on June 30, 2023, and 3/48ths (978 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.

Issuer

Monopar Therapeutics

CIK 0001645469

Entity typeother

Related Parties

1
  • filerCIK 0001863624

Filing Metadata

Form type
4
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 7:44 PM ET
Size
9.6 KB